TGF-beta/Smad
TGF-beta/Smad inhibitors are compounds that interfere with the TGF-beta (Transforming Growth Factor-beta) signaling pathway, which is mediated by Smad proteins. This pathway is involved in the regulation of cell growth, differentiation, apoptosis, and stem cell function. Dysregulation of TGF-beta/Smad signaling is associated with cancer, fibrosis, and other diseases. Inhibitors of this pathway are important tools for studying these conditions and developing potential therapies. At CymitQuimica, we provide TGF-beta/Smad inhibitors to support your research in cell signaling, oncology, and tissue repair.
Read more
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | TGFβRI-IN-3 REF: TM-T9523CAS: 2763602-67-9 | 98.02% | 86.00 €~2,535.00 € | Wed 19 Mar 25 |
TGFβRI-IN-3
CAS:2763602-67-9
TGFβRI-IN-3 inhibits TGFβR1 with an IC 50 of 0.79 nM with 2000-fold selectivity against MAP4K4.
Formula:
C28H23N3O2S
Purity:
98.02%
Color and Shape:
Soild
Molecular weight:
465.57
Ref: TM-T9523
| 1mg | 86.00 € | ||
| 5mg | 183.00 € | ||
| 10mg | 291.00 € | ||
| 25mg | 572.00 € | ||
| 50mg | 891.00 € | ||
| 100mg | 1,280.00 € | ||
| 500mg | 2,535.00 € | ||
| 1mL*10mM (DMSO) | 186.00 € |
Estimated delivery in United States, on Wednesday 19 Mar 2025
